Quote | RxSight Inc. (NASDAQ:RXST)
Last: | $47.44 |
---|---|
Change Percent: | 1.43% |
Open: | $46.98 |
Close: | $46.77 |
High: | $48.02 |
Low: | $46.38 |
Volume: | 221,925 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | RxSight Inc. (NASDAQ:RXST)
2024-07-16 07:00:00 ET Summary Small-cap stocks struggled in the first half of 2024 due to economic concerns and higher interest rates, lagging behind broader market indexes. The outlook for small caps in the second half depends on timely interest rate cuts and stable economic gro...
2024-07-10 16:43:45 ET Summary Today, we revisit RxSight, Inc., whose stock has nearly quintupled since the end of 2022. The company has a solid business model and loss estimates have come down substantially since we last looked in October of last year. That said, the stock tr...
Message Board Posts | RxSight Inc. (NASDAQ:RXST)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...
ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it has closed its underwritten public offering of 2,053,571 s...